A replication-defective adenovirus vector carrying the reporter gene encoding β-galactosidase was used to transfect organotypic slices maintained in culture for up to 1 month. Three different delivery systems were used to inoculate the viral solution, either into the culture medium, or directly onto the surface of the slices or by microinjection into the tissue. Using the two first paradigms β-galactosidase expressing cells were mostly of glial phenotype and distributed throughout the slices without any specific regional pattern. In contrast, microinjection of the adenovirus resulted in a large number of both infected neurones and glia, concentrated at the site of injection.This method thus appears to be able to circumvent some of the constraints and limitations associated with in vivo gene transfer.
Introduction
In vivo gene transfer is an emerging technology with applications that are developing rapidly for both basic research and clinical medicine (Friedmann 1989 , 1993 , Mulligan 1993 , Roemer & Friedmann 1992 . The recent discovery of virus vectors suitable for the delivery of foreign genes to neuronal or glial cells in vivo (see Breakefield 1993 , Neve 1993 ) has led to new approaches for neuroscience research and studies of neurological disorders.A further advance was the development of adenoviral vectors for transfecting foreign genes into nervous cells (Akli et al. 1993 , Bajocchi et al. 1993 , Davidson et al. 1993 , Le Gal La Salle et al. 1993 , Ridoux et al. 1994b . Recombinant adenoviral vectors containing the E. coli lacZ reporter gene (Ad. RSVβgal) efficiently infect nerve cells both in vitro and in vivo. In culture, a large variety of nerve cells (cell lines, primary astrocytes or neurones) are tranfected in nearly 100% of the cases following inoculation of the culture medium with recombinant adenovirus (Caillaud et al. 1993 , Le Gal La Salle et al. 1993 . In the living rat brain, cells located around the site of injection can express the transgene after stereotaxic administration of the virus into various brain regions. Using anatomical, morphological and immunohistochemical criteria various cell types were all shown to express the transgene: neurones, microglial cells, astrocytes, oligodendrocytes and ependymal cells. Expression of the transgene was detected up to 6 months after infection. It was also reported that cells transfected with the adenoviral vector and subsequently grafted into various brain structures can survive and express the transgene for several months (Ridoux et al. 1994a ).
Here we show that adenovirus gene transfer and expression can be achieved in organotypic slice cultures, as demonstrated recently using herpes virus vectors (Bahr et al. 1994 ,Casaccia-Bonnefil et al. 1993b .Experiments were first performed either by supplementing the culture medium with the viral solution in or by direct inoculation onto the top surface of the slices.These two delivery systems resulted in diffuse and non-specific gene transfer and we thus introduced a third mode of injection: microinjection into the slices. This method gave very efficient transfection and expression, low cytotoxicity and good and reproducible targeting of the transgene into discrete areas. Microinjection of the adenoviral solution was tested in explants of the hippocampus, the cerebellar cortex and the subtantia nigra. Cells expressing the transgene were identified with appropriate immunohistochemical markers.
